PICA-PICA Bypass versus OA-PICA Bypass for Treating Posterior Circulation Aneurysms: A Systematic Review and Comparative Meta-Analysis.
Aneurysm
Bypass
Occipital
PICA
Revascularization
Journal
World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275
Informations de publication
Date de publication:
06 Mar 2024
06 Mar 2024
Historique:
received:
15
02
2024
accepted:
28
02
2024
medline:
9
3
2024
pubmed:
9
3
2024
entrez:
8
3
2024
Statut:
aheadofprint
Résumé
When traditional therapies are unsuitable, revascularization becomes essential for managing posterior inferior cerebellar artery (PICA) or vertebral artery aneurysms. Notably, the PICA-PICA bypass has emerged as a promising option, overshadowing the occipital artery-PICA (OA-PICA) bypass. To compare the safety and efficacy of OA-PICA and PICA-PICA bypasses. Following PRISMA guidelines, we conducted a systematic review and meta-analysis to evaluate the safety and efficacy of OA-PICA and PICA-PICA bypasses for treating posterior circulation aneurysms. We analyzed 13 studies for the PICA-PICA bypass and 16 studies on the OA-PICA bypass, involving 84 and 110 patients, respectively. The median average follow-up for PICA-PICA bypass was 8 months (2 - 50.3 months), while for OA-PICA, it was 27.8 months (6 - 84 months). The patency rate for OA-PICA was 97% (95% CI: 92% - 100%) and 100% (95% CI: 95% - 100%) for PICA-PICA. Complication rates were 29% (95% CI: 10% - 47%) for OA-PICA and 12% (95% CI: 3% - 21%) for PICA-PICA. Good clinical outcomes were observed in 71% (95% CI: 52% - 90%) of OA-PICA patients and 87% (95% CI: 75% - 100% of PICA-PICA patients. Procedure-related mortality was 1% (95% CI: 0% - 6%) for OA-PICA and 1% (95% CI: 0% - 10%) for PICA-PICA. Both procedures have demonstrated promising results in efficacy and safety. PICA-PICA exhibits slightly better patency rates, better clinical outcomes, and fewer complications, but with a lack of substantial follow-up and a smaller sample size. The choice between these procedures should be based on the surgeon's expertise and the patient's anatomy.
Sections du résumé
BACKGROUND
BACKGROUND
When traditional therapies are unsuitable, revascularization becomes essential for managing posterior inferior cerebellar artery (PICA) or vertebral artery aneurysms. Notably, the PICA-PICA bypass has emerged as a promising option, overshadowing the occipital artery-PICA (OA-PICA) bypass.
PURPOSE
OBJECTIVE
To compare the safety and efficacy of OA-PICA and PICA-PICA bypasses.
METHODS
METHODS
Following PRISMA guidelines, we conducted a systematic review and meta-analysis to evaluate the safety and efficacy of OA-PICA and PICA-PICA bypasses for treating posterior circulation aneurysms.
RESULTS
RESULTS
We analyzed 13 studies for the PICA-PICA bypass and 16 studies on the OA-PICA bypass, involving 84 and 110 patients, respectively. The median average follow-up for PICA-PICA bypass was 8 months (2 - 50.3 months), while for OA-PICA, it was 27.8 months (6 - 84 months). The patency rate for OA-PICA was 97% (95% CI: 92% - 100%) and 100% (95% CI: 95% - 100%) for PICA-PICA. Complication rates were 29% (95% CI: 10% - 47%) for OA-PICA and 12% (95% CI: 3% - 21%) for PICA-PICA. Good clinical outcomes were observed in 71% (95% CI: 52% - 90%) of OA-PICA patients and 87% (95% CI: 75% - 100% of PICA-PICA patients. Procedure-related mortality was 1% (95% CI: 0% - 6%) for OA-PICA and 1% (95% CI: 0% - 10%) for PICA-PICA.
CONCLUSION
CONCLUSIONS
Both procedures have demonstrated promising results in efficacy and safety. PICA-PICA exhibits slightly better patency rates, better clinical outcomes, and fewer complications, but with a lack of substantial follow-up and a smaller sample size. The choice between these procedures should be based on the surgeon's expertise and the patient's anatomy.
Identifiants
pubmed: 38458251
pii: S1878-8750(24)00370-X
doi: 10.1016/j.wneu.2024.02.153
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.